Used in research and diagnostic applications to detect and study Cadherin-17 (CDH17) expression in tissues, particularly in gastrointestinal and liver cancers. The antibody serves as a reference tool in immunoassays such as immunohistochemistry (IHC) and flow cytometry to identify tumor markers and support the development of targeted cancer therapies. It is also employed in the validation of CDH17 as a potential biomarker for metastatic adenocarcinomas, especially colorectal and hepatocellular carcinomas. Due to its specific binding properties, it aids in the purification and characterization of CDH17 for use in therapeutic antibody development and preclinical studies.